Enterprise Implementations: The Common Pattern

These implementations share critical characteristics:

1. Blockchain enhances existing infrastructure—EDI and traditional systems continue operating
2. Focus on high-value verification—not every transaction goes on blockchain, just critical proof points
3. Measurable cost savings—43% lower infrastructure costs, €6 billion fraud prevention, rapid pharmaceutical traceability
4. Practical supplier integration—small suppliers use simple mobile interfaces, large suppliers integrate systems
5. Industry collaboration—competitors share platforms because no single party controls the network (e.g., MOBI initiative, FDA pilot consortium)